Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection.

A. Mathioudakis (Manchester, United Kingdom), M. Moberg (Hvidovre, Denmark), J. Janner (Hvidovre, Denmark), P. Alonso-Coello (Barcelona, Spain), J. Vestbo (Manchester, United Kingdom)

Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 609
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mathioudakis (Manchester, United Kingdom), M. Moberg (Hvidovre, Denmark), J. Janner (Hvidovre, Denmark), P. Alonso-Coello (Barcelona, Spain), J. Vestbo (Manchester, United Kingdom). Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection.. 609

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: